BRPI0606974A2 - uso de compostos de complexo de ferro(iii) - Google Patents

uso de compostos de complexo de ferro(iii)

Info

Publication number
BRPI0606974A2
BRPI0606974A2 BRPI0606974-6A BRPI0606974A BRPI0606974A2 BR PI0606974 A2 BRPI0606974 A2 BR PI0606974A2 BR PI0606974 A BRPI0606974 A BR PI0606974A BR PI0606974 A2 BRPI0606974 A2 BR PI0606974A2
Authority
BR
Brazil
Prior art keywords
iii
complex compounds
iron complex
iron
carbohydrates
Prior art date
Application number
BRPI0606974-6A
Other languages
English (en)
Inventor
Jessica Tanner-Baumgartner
Ranjeet Chandra
Peter Geisser
Original Assignee
Vifor Internat Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Internat Ag filed Critical Vifor Internat Ag
Publication of BRPI0606974A2 publication Critical patent/BRPI0606974A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Abstract

USO DE COMPOSTOS DE COMPLEXO DE FERRO(III). A presente invenção refere-se a novos usos terapêuticas de compostos de complexo de ferro(III) com carboidratos ou derivados dos mesmos, no preparo de um medicamento para aperfeiçoamento da defesa imune e/ou desempenho cerebral.
BRPI0606974-6A 2005-02-09 2006-01-18 uso de compostos de complexo de ferro(iii) BRPI0606974A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100907 2005-02-09
PCT/EP2006/050276 WO2006084782A1 (de) 2005-02-09 2006-01-18 Verwendung von eisen(iii)-komplexverbindungen

Publications (1)

Publication Number Publication Date
BRPI0606974A2 true BRPI0606974A2 (pt) 2009-07-28

Family

ID=34938674

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606974-6A BRPI0606974A2 (pt) 2005-02-09 2006-01-18 uso de compostos de complexo de ferro(iii)

Country Status (26)

Country Link
US (2) US8722101B2 (pt)
EP (1) EP1848446B1 (pt)
JP (1) JP5060312B2 (pt)
KR (1) KR20070107106A (pt)
CN (1) CN101155593A (pt)
AT (1) ATE445406T1 (pt)
AU (1) AU2006212322B2 (pt)
BR (1) BRPI0606974A2 (pt)
CA (1) CA2597154C (pt)
CR (1) CR9300A (pt)
CY (1) CY1109685T1 (pt)
DE (1) DE502006005100D1 (pt)
DK (1) DK1848446T3 (pt)
ES (1) ES2333814T3 (pt)
HR (1) HRP20100027T1 (pt)
IL (1) IL185020A (pt)
MX (1) MX2007009588A (pt)
NO (1) NO20074536L (pt)
PL (1) PL1848446T3 (pt)
PT (1) PT1848446E (pt)
RU (1) RU2359680C2 (pt)
SI (1) SI1848446T1 (pt)
TN (1) TNSN07307A1 (pt)
UA (1) UA88347C2 (pt)
WO (1) WO2006084782A1 (pt)
ZA (1) ZA200707716B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
KR101905340B1 (ko) 2006-01-06 2018-10-05 루이트폴드 파머수티컬스, 인코퍼레이티드 철을 투여하기 위한 방법 및 조성물
EP2165713B1 (en) * 2008-09-19 2012-11-14 Nestec S.A. Whey and thymus function
LT2411053T (lt) * 2009-03-25 2017-04-10 Pharmacosmos Holding A/S Stabilus geležies oligosacharido junginys
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
US11395502B2 (en) * 2012-10-18 2022-07-26 Patrick Monsivais Formulation for iron supplements
CA2896983A1 (en) * 2013-03-28 2014-10-02 Vifor (International) Ag Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
KR20150078375A (ko) * 2013-12-30 2015-07-08 한화케미칼 주식회사 철산화물 나노입자를 포함하는 철결핍증의 예방 또는 치료용 약학 조성물
FR3075001B1 (fr) * 2017-12-14 2021-09-10 Tereos Starch & Sweeteners Belgium Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau
CN114288320A (zh) * 2021-12-29 2022-04-08 珠海天翼医药技术开发有限公司 一种猪用口服补铁剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076798A (en) * 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3766165A (en) * 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
DE4421159C1 (de) 1994-06-20 1995-08-24 Thomas Bruns Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
AU2002220280A1 (en) 2000-12-07 2002-06-18 Ad "Zdravlje" Farmaceutsko - Hemijska Industrija, Centar Za Istrazivanje I Razvoj Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
PL373506A1 (en) * 2001-04-10 2005-09-05 Danisco Usa Polymerization of mono and disaccharides with monocarboxylic acids and lactones
MXPA04009770A (es) 2002-04-09 2004-12-13 Pharmacosmos Holding As Compuestos de dextrina de hierro para el tratamiento de la anemia por deficiencia de hierro.
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
ES2333814T3 (es) 2010-03-01
CN101155593A (zh) 2008-04-02
MX2007009588A (es) 2007-09-12
IL185020A (en) 2013-10-31
EP1848446B1 (de) 2009-10-14
RU2007133509A (ru) 2009-03-20
UA88347C2 (ru) 2009-10-12
IL185020A0 (en) 2007-12-03
HRP20100027T1 (hr) 2010-02-28
CA2597154C (en) 2011-03-15
TNSN07307A1 (en) 2008-12-31
US8722101B2 (en) 2014-05-13
EP1848446A1 (de) 2007-10-31
ATE445406T1 (de) 2009-10-15
KR20070107106A (ko) 2007-11-06
AU2006212322A1 (en) 2006-08-17
US20140187514A1 (en) 2014-07-03
PL1848446T3 (pl) 2010-03-31
ZA200707716B (en) 2008-06-25
DE502006005100D1 (de) 2009-11-26
NO20074536L (no) 2007-11-05
PT1848446E (pt) 2009-12-21
CR9300A (es) 2007-12-07
DK1848446T3 (da) 2010-02-15
US20080214496A1 (en) 2008-09-04
RU2359680C2 (ru) 2009-06-27
SI1848446T1 (sl) 2010-01-29
AU2006212322B2 (en) 2012-01-19
JP2008530049A (ja) 2008-08-07
JP5060312B2 (ja) 2012-10-31
CA2597154A1 (en) 2006-08-17
CY1109685T1 (el) 2014-08-13
WO2006084782A1 (de) 2006-08-17

Similar Documents

Publication Publication Date Title
BRPI0606974A2 (pt) uso de compostos de complexo de ferro(iii)
TW200626157A (en) HCV inhibiting bi-cyclic pyrimidines
TW200716631A (en) Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
MX2010004576A (es) Derivados de pirimidina novedosos.
WO2006124861A3 (en) Benzofuran compounds
MX343042B (es) Compuestos heteroarilicos biciclicos.
ZA200807274B (en) Novel pyridine derivatives
UA85559C2 (en) Aminobenzophenone compounds
TW200942524A (en) Novel aminomethyl benzene derivatives
WO2010004197A3 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
EA200870421A1 (ru) Димеры производных артемизинина, их получение и их применение в терапии
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
TW200942530A (en) Pyridine compounds
EA201070009A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
MA35816B1 (fr) Dérivés d'aniline, leur préparation et leur application thérapeutique
TW200726763A (en) Novel compound
WO2007150008A3 (en) Polypeptides from african swine virus as vaccines for preventive and therapeutic use
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
WO2007121883A3 (de) 1,4:3,6-dianhydromannitol-derivate und deren verwendung
EA200870565A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламидобензазепины, их получение, содержащие их композиции и применение
MY150436A (en) 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
ECSP078024A (es) Inhibidores de la adenilato ciclasa soluble
WO2009008888A8 (en) African swine virus polypeptides as vaccines and its therapeutic use thereof
DK1962822T3 (da) Terapi af maligne neoplasier
EA200870566A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламидобензотиазепины, их получение, композиции, содержащие их, и применение

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]